Category: cardiology retractions

Retraction Watch, Noah Webster style, cardiology edition

intjcardiolPlagiarism and duplication might involve the same act — the misuse of text and/or data — but they are different species. Take it from Eldon Smith, who as editor of the Canadian Journal of Cardiology defined the two acts of misconduct for his readers:

Plagiarism is the appropriation of another person’s ideas, processes, results or words without giving appropriate credit (1). One usually thinks of plagiarism in science as publishing phrases, sentences or passages (without attribution) that were previously published by someone else. …

If an author publishes the same article twice, he or she is guilty not only of the misconduct of duplicate publication, but also of plagiarism; this time, the author has plagiarized himself or herself. Unfortunately, such blatant misconduct is not rare. … It is difficult to understand how this can be interpreted as an honest error.

Perhaps the editors of the International Journal of Cardiology might want to take a look at Smith’s editorial. Continue reading Retraction Watch, Noah Webster style, cardiology edition

Study of blood pressure drug valsartan retracted

matsubaraHiroaki Matsubara, a prominent cardiologist with five Expressions of Concern and two retractions for his CV, has another retraction.

As Larry Husten, who first reported the retraction at Forbes, notes, the notice for 2009’s “Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study,” which appeared in the European Heart Journal, says very little: Continue reading Study of blood pressure drug valsartan retracted

Duplication leads to retraction of 1997 paper on heart disease genes

crit rev clin lab sciA top cardiology researcher, Robert Hegele, of the Robarts Research Institute at the University of Western Ontario, has retracted a 15-year-old review after editors were made aware that it was “very similar” to another of his reviews.

Here’s the December 2012 notice for the paper, which has been cited 23 times, according to Thomson Scientific’s Web of Knowledge: Continue reading Duplication leads to retraction of 1997 paper on heart disease genes

Journal retracts two papers by Japanese cardiologist under investigation

matsubaraThe Circulation Journal, the official organ of the Japanese Circulation Society, is retracting two papers by Hiroaki Matsubara, lead researcher on the Kyoto Heart Study, for unreliable findings. Matsubara’s institution, Kyoto Prefectural University, confirmed to us last March that it was investigating the prominent cardiologist.

The work of Matsubara came into question last year when the American Heart Association issued an expression of concern for five papers the society published in its journals. Larry Husten, at Forbes/CardioBrief, reports today that the two retracted articles were “Effects of Valsartan on Cardiovascular Morbidity and Mortality in High-Risk Hypertensive Patients With New-Onset Diabetes Mellitus: Sub-Analysis of the KYOTO HEART Study,” published in September 2012; and “Enhanced cardiovascular protective effects of valsartan in high-risk hypertensive patients with left ventricular hypertrophy: Sub-analysis of the KYOTO HEART study,” which appeared in March 2011.

The retraction notice for the most recent paper states: Continue reading Journal retracts two papers by Japanese cardiologist under investigation

First retraction for Eric Smart, who faked dozens of images, appears in PNAS

Eric J. Smart, via U Kentucky
Eric J. Smart, via U Kentucky

Eric Smart, who as we reported in November was sanctioned by the Office of Research Integrity (ORI) for faking dozens of images in ten papers and seven grants over the past decade, has had his first retraction.

Here’s the December 24 notice, from PNAS: Continue reading First retraction for Eric Smart, who faked dozens of images, appears in PNAS

Concern — in triplicate — arrives for Poldermans papers

Jacc1212coverThe Journal of the American College of Cardiology, or JACC, has issued expressions of concern for three papers by Don Poldermans, the Dutch cardiologist who was fired earlier this year amid allegations of misconduct.

Cardiobrief’s Larry Husten had the story first.

The, um, heart of the matter is that neither the investigators at Erasmus Medical Center, Poldermans’ former institution, nor the JACC editors, can say whether the researchers conduct rose to the level of fabricating data. As the Notice of Concern states: Continue reading Concern — in triplicate — arrives for Poldermans papers

Two patch-clamping retractions in PNAS and the JCI after first author admits image manipulation

jci1212A group of cardiology researchers formerly of the University of Cologne has retracted two papers, after investigations into allegations of misconduct led to an admission of guilt by one of the lab’s junior members.

Here’s the first retraction, for “Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes,” published last week in the Journal of Clinical Investigation: Continue reading Two patch-clamping retractions in PNAS and the JCI after first author admits image manipulation

Heart retracts stent-ReoPro paper over data dispute with authors (save one)

We’re a few months late on this one, but Heart, a BMJ title, issued a fascinating retraction notice in August about a meta-analysis on percutaneous coronary intervention (that’s stenting to you and me) after suffering a heart attack, and the drug abciximab, which is used to prevent clotting and additional near-term heart attacks. Abciximab is sold as ReoPro by Eli Lilly.

The article, “Clinical impact of intracoronary abciximab in patients undergoing primary percutaneous coronary intervention: an individual patient-data pooled analysis of randomised studies,” was published last May. But according to the retraction notice, the authors had neglected to include fresh data, already in the literature before their paper went live, that contradicted their overall findings.

Here’s the notice: Continue reading Heart retracts stent-ReoPro paper over data dispute with authors (save one)

Odd: Retractions 18 and 19 for Dipak Das, and a new paper in the same journal, as if nothing were amiss

Dipak Das, the resveratrol researcher found guilty of more than 100 counts of misconduct by the University of Connecticut, has two more retractions for his resume. But that’s not the most interesting part of this post, so keep reading after the notices.

Both retractions appeared in the October 2012 issue of the Journal of Cellular and Molecular Medicine. Here’s the first notice: Continue reading Odd: Retractions 18 and 19 for Dipak Das, and a new paper in the same journal, as if nothing were amiss

Transcendental meditation paper pulled minutes before publication appears in a new journal

In June of last year, the Archives of Internal Medicine yanked a paper just 12 minutes before it was scheduled to publish, to

…allow time for review and statistical analysis of additional data not included in the original paper that the authors provided less than 24 hours before posting…

A year later, the lead author told us the paper was still under review. Now, as Larry Husten of CardioBrief reports today, it has finally been published — but in a different journal altogether: Continue reading Transcendental meditation paper pulled minutes before publication appears in a new journal